Business & Finance
DURECT Corporation announces third quarter financial results
Published in Law and Health Weekly, December 9th, 2006
Total revenues were $5.1 million for the three months ended September 30, 2006, compared to $8.6 million for the same period in 2005. Net loss for the three months ended September 30, 2006 was $8.6 million, compared to a net loss of $3.0 million for the same period in 2005. Cash used in operating activities was $3.1 million for the three months ended September 30, 2006, compared to $1.1 million of cash used in operating activities for the same period in 2005.
At September 30, 2006, DURECT had cash and investments of $74.3 million, including $1.5...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Behavior
Scientists at City University of New York, Department of Psychology target behavior - Business & Finance
Acadia Pharmaceuticals posts loss of $11.3 million - Business & Finance
Angiotech Pharmaceuticals reports income of $0.19 per share - Business & Finance
Bentley Pharmaceuticals experiences 7% revenue growth - Business & Finance
Connetics reports third quarter financial results - Business & Finance
Cross Country Healthcare reports $162.9 million for third quarter 2006 - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
